Related Experiment Videos

[Mnesic function in 5 patients suffering from central idiopathic diabetes insipidus (author's transl)]

Acta Psychiatrica Belgica
|September 1, 1980
PubMed

Insights

Central idiopathic diabetes insipidus (CIDI) patients showed improved memory function with vasopressin treatment (DDAVP). Therapy benefits were most notable in those with lower baseline cognitive scores.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Psychology

Context:

  • Central idiopathic diabetes insipidus (CIDI) is a condition affecting water balance.
  • Mnesic (memory) function is crucial for daily activities.
  • Treatment with desmopressin (DDAVP) is standard for CIDI.

Purpose:

  • To investigate the impact of vasopressin (DDAVP) on mnesic function in CIDI patients.
  • To assess cognitive performance before and after DDAVP therapy withdrawal and reintroduction.

Summary:

  • Mnesic function was evaluated in 5 CIDI patients off and on DDAVP.
  • Baseline cognitive scores were generally low, with a notable deficit on the Benton test.
  • DDAVP therapy led to improved cognitive scores, particularly in patients with poorer initial performance.

Impact:

  • Findings suggest vasopressin may positively influence memory function.
  • The study highlights potential indirect cognitive effects of DDAVP via metabolic and sleep regulation.
  • Further research is needed to isolate the direct central effects of vasopressin on cognition.

Related Concept Videos